Market-Moving News for June 10th
$DSY
$KKR
$SKYE
Containers/Packaging
Consumer Discretionary
Investment Managers
Finance
Get the next $DSY alert in real time by email
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 1/28/2026 | $144.00 | Hold → Buy | HSBC Securities | |
| 1/14/2026 | $131.00 | Buy → Hold | TD Cowen | |
| 12/11/2025 | $176.00 | Buy | UBS | |
| 10/6/2025 | $2.00 | Buy → Hold | Craig Hallum | |
| 10/6/2025 | $2.00 | Overweight → Neutral | Cantor Fitzgerald | |
| 8/15/2025 | $10.00 | Outperform | Evercore ISI | |
| 7/14/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | ||
| 7/9/2025 | $142.00 | Buy → Hold | HSBC Securities |
SHENZHEN, China, Feb. 11, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company") (NASDAQ:DSY) today announced that the previously disclosed reverse share split and related corporate actions, including the change in par value, reclassification, and CUSIP number change, will not become effective on February 12, 2026, as previously anticipated. The renewed effective date of the reverse share split and related corporate actions will be announced at a later time. The Company intends to issue a further press release once the new effective date has been determined. About Big Tree Cloud Founded in 2020, Big Tree Cloud is positioned as an international capital platform focused on indus
SHENZHEN, China, Feb. 11, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company") (NASDAQ:DSY) today announced that it held an extraordinary general meeting on January 30, 2026, at which the shareholders approved the consolidation of every 20 ordinary shares into one ordinary share and the adoption of a dual-class share structure (comprising Class A and Class B ordinary shares).The Company's Class A ordinary shares are expected to begin trading on The Nasdaq Capital Market at the open of business on February 12, 2026, and will continue to trade under the symbol "DSY" and the new CUSIP number G1263B132. Reverse Stock Split The Reverse Stock Split has been approved by the Company
HMC Capital (ASX: HMC) and KKR, a leading global investment firm, today announced the establishment of a new strategic partnership under which KKR-managed funds will invest up to $603 million into HMC's Energy Transition Platform (the "Platform"). The investment will introduce KKR as a strategic partner alongside HMC in the Platform's existing 652MW operational assets and its 5.7GW BESS and wind development pipeline. KKR's investment will support the Platform's continued expansion, including the development of new battery storage and wind projects critical to grid reliability and Australia's energy transition. This press release features multimedia. View the full release here: https://www.
6-K - Big Tree Cloud Holdings Ltd (0001999297) (Filer)
6-K - Big Tree Cloud Holdings Ltd (0001999297) (Filer)
PRE 14A - KKR & Co. Inc. (0001404912) (Filer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - Skye Bioscience, Inc. (0001516551) (Issuer)
4 - Skye Bioscience, Inc. (0001516551) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $144.00
TD Cowen downgraded KKR from Buy to Hold and set a new price target of $131.00
UBS resumed coverage of KKR with a rating of Buy and set a new price target of $176.00
KKR & Co. Inc. (NYSE:KKR) today reported its fourth quarter 2025 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205483801/en/ A conference call to discuss KKR's financial results will be held today, Thursday, February 5, 2026 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Ce
Marks one of the largest digital infrastructure transactions in Southeast Asia Global investment firm KKR, Asia's leading communications technology group Singtel, and ST Telemedia today announced the signing of definitive agreements under which funds managed by KKR and Singtel (together, the "Consortium") will acquire the remaining 82% stake in ST Telemedia Global Data Centres ("STT GDC" or the "Company"), a leading data centre colocation services provider, from founding shareholder ST Telemedia for a total consideration of S$6.6 billion (approximately US$5.1 billion). This represents an implied enterprise value of approximately S$13.8 billion (approximately US$10.9 billion), including le
PHILADELPHIA and NEW YORK, Jan. 21, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its fourth quarter and full year 2025 results after the close of trading on the New York Stock Exchange on Wednesday, February 25, 2026. FSK will host its fourth quarter and full year 2025 results conference call via live webcast on Thursday, February 26, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the For Investors section of FSK's website at www.fskkrcapitalcorp.com under Events
22.3% total weight loss at 52 weeks with nimacimab (200 mg dose) + semaglutide (2.4 mg) combination — no plateau observed, suggesting potential for further efficacy beyond one year and at higher nimacimab dosesWeight regain during treatment interruption reduced by over 50% — nimacimab + semaglutide cohort regained only 17.8% of lost weight vs. 37.3% for semaglutide alone during 13-week off-therapy follow-up, demonstrating durability advantageStrong safety and tolerability profile maintained — no serious adverse events or adverse events of special interest reported during the 52-week extension period SAN DIEGO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye")
Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120305013/en/ Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential
SHENZHEN, China, Jan. 2, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company", or "Big Tree Cloud") (NASDAQ:DSY) today announced its expansion into new AI business lines and the appointment of key talents to support its long-term growth strategy. Due to business adjustments, the Company has decided to restructure the relevant teams. Mr. Yumao Huang has stepped down from the Board of Directors (the "Board"). Mr. Huang has served as a director of the Company since March 2024. His resignation is not a result of any disagreement with management of the Company or the Board, and there is no matter relating to his resignation that needs to be brought to the attention of the Company'
SC 13G/A - Skye Bioscience, Inc. (0001516551) (Subject)
SC 13G/A - Skye Bioscience, Inc. (0001516551) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
